推荐产品
抗体产品类型
secondary antibodies
质量水平
用途
sufficient for 2,000 tests ELISA, Immunoblotting
sufficient for 200 tests Immunohistology
运输
wet ice
储存温度
2-8°C
靶向翻译后修饰
unmodified
正在寻找类似产品? 访问 产品对比指南
一般描述
包含可与一抗联用的通用试剂，适用于免疫组化、ELISA和免疫印迹。
ExtrAvidin®是一种形式独特的亲和素，由Sigma独家供货，可将亲和素对生物素的高特异性和高亲和性与在生理条件下的低非特异性有机结合在一起。ExtrAvidin®过氧化物酶具有灵敏度高、本底水平低的特点。
ExtrAvidin®是一种形式独特的亲和素，由Sigma独家供货，可将亲和素对生物素的高特异性和高亲和性与在生理条件下的低非特异性有机结合在一起。ExtrAvidin®过氧化物酶具有灵敏度高、本底水平低的特点。
应用
Applications in which this antibody has been used successfully, and the associated peer-reviewed papers, are given below.
Immunohistochemistry (1 paper)
Immunohistochemistry (1 paper)
特点和优势
- 可用于免疫组化、ELISA和免疫印迹检测。
- 使用human IgG和IgM对亲和纯化的抗体进行吸附，可最大限度减少交叉反应。
- 生物素标记的抗体含有一段间隔肽链，可提高其与ExtrAvidin® 偶联物的亲和性。
组分
• 3 mL ExtrAvidin®-过氧化物酶
• 3 mL生物素标记的二抗
• 附带完整使用说明和实验方案
• 3 mL生物素标记的二抗
• 附带完整使用说明和实验方案
法律信息
ExtrAvidin is a registered trademark of Merck KGaA, Darmstadt, Germany
免责声明
For U.S. Customers: Contains mercury; Do not place in trash - dispose according to local, state, or federal laws.
未找到合适的产品？
试试我们的产品选型工具.
储存分类代码
12 - Non Combustible Liquids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)
法规信息
新产品
从最新的版本中选择一种：
分析证书(COA)
Lot/Batch Number
Matheus L Medeiros et al.
Journal of inflammation research, 14, 6477-6489 (2021-12-10)
Methylglyoxal (MGO) is a highly reactive dicarbonyl species implicated in diabetic-associated diseases. Acute lung injury (ALI) symptoms and prognosis are worsened by diabetes and obesity. Here, we hypothesized that elevated MGO levels aggravate ALI, which can be prevented by metformin.
Akila L Oliveira et al.
Frontiers in physiology, 13, 860342-860342 (2022-04-15)
Methylglyoxal (MGO) is a highly reactive dicarbonyl compound implicated in diabetes-associated diseases. In vascular tissues, MGO induces the formation of advanced glycation end products (AGEs) that bounds its receptor RAGE, initiating the downstream tissue injury. Outside the cardiovascular system, MGO
Neuroprotective action of diazepam at very low and moderate doses in Alzheimer's disease model rats.
Vladimirs Pilipenko et al.
Neuropharmacology, 144, 319-326 (2018-11-09)
Early manifestations of Alzheimer's disease (AD) include neuroinflammation, disrupted neurotransmission and cognitive deficits. Impairment of the GABAergic system is essentially involved in the pathogenesis of AD. Traditionally, agonists of GABAA receptors at doses above 1 mg/kg are known to possess memory
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门